Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.50 |
| ▸ | MEN1 | O00255 | 4/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | F2 | P00734 | 1/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | DRD1 | P21728 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.50 |
| ▸ | DRD3 | P35462 | 1/20 | 0.50 |
| ▸ | KDR | P35968 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL146313 | 1.00 | KMT2A (0.50) | KMT2AMEN1HTTLMNAF2 | |
| Iodide SCHEMBL11279046 | 0.98 | KMT2A (0.48) | KMT2AMEN1HTTLMNAF2 | |
| Hydrochloric Acid SCHEMBL40555 | 0.98 | MAPT (0.50) | KMT2AMEN1HTTLMNAF2 | |
| SCHEMBL12273001 | 0.90 | HTR3A (0.48) | KMT2AMEN1HTTLMNAF2 | |
| Iodide SCHEMBL12813166 | 0.88 | HTR3A (0.47) | KMT2AMEN1HTTLMNAF2 | |
| SCHEMBL12620639 | 0.88 | KDM4E (0.43) | KMT2AMEN1HTTLMNAF2 | |
| SCHEMBL11281816 | 0.88 | ALDH1A1 (0.44) | KMT2AMEN1HTTLMNAF2 | |
| Iodide SCHEMBL12813168 | 0.87 | HTR3A (0.46) | KMT2AMEN1HTTLMNAF2 | |
| Acetic Acid SCHEMBL755555 | 0.85 | NQO2 (0.42) | KMT2AMEN1HTTLMNAF2 | |
| Acetic Acid SCHEMBL755557 | 0.85 | CHEK1 (0.41) | KMT2AMEN1HTTLMNAF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12441694-B2 | Process for the preparation of methylene blue | DISHMAN CARBOGEN AMCIS LTD. (IN) | 2025-10-14 | — | — | US | disclosed |
| US-20250222006-A1 | METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS | WISTA LABORATORIES LTD. (SG) | 2025-07-10 | — | — | US | disclosed |
| CN-117209450-A | Chemical synthesis method of diaminophenothiazinium compound including methyl sulfonium chloride (MTC) | 维斯塔实验室有限公司 | 2023-12-12 | — | — | CN | disclosed |
| CN-117209450-A | Chemical synthesis method of diaminophenothiazinium compound including methyl sulfonium chloride (MTC) | 维斯塔实验室有限公司 | 2023-12-12 | — | — | CN | disclosed |
| CN-110092764-B | Chemical synthesis method of diaminophenothiazinium compound including methyl sulfonium chloride (MTC) | 维斯塔实验室有限公司 | 2023-09-15 | — | — | CN | disclosed |
| CN-110092764-B | Chemical synthesis method of diaminophenothiazinium compound including methyl sulfonium chloride (MTC) | 维斯塔实验室有限公司 | 2023-09-15 | — | — | CN | disclosed |
| US-20230138553-A1 | A Process for the Preparation of Methylene Blue | DISHMAN CARBOGEN AMCIS LTD. (IN) | 2023-05-04 | — | — | US | disclosed |
| EP-4121757-A1 | INDICATOR FILM | Insignia Technologies Limited (GB) | 2023-01-25 | — | — | EP | disclosed |
| EP-4110735-A1 | A PROCESS FOR THE PREPARATION OF METHYLENE BLUE | Dishman Carbogen Amcis Ltd. (IN) | 2023-01-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250222006-A1 | METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS | MB, TPMT, HBB | KMT2A 936/4885MEN1 330/4885HTT 567/4885 |
| US-12441694-B2 | Process for the preparation of methylene blue | B2M, LMNB2, LMNA | KMT2A 2037/4885MEN1 208/4885HTT 2338/4885 |
| US-20230138553-A1 | A Process for the Preparation of Methylene Blue | B2M, PURB, POLM | KMT2A 884/4885MEN1 2607/4885HTT 2535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.